Merck, AstraZeneca, Bristol Myers in Medicare drug price negotiations
, , and Boehringer Ingelheim on Wednesday told CNBC they will agree to participate in the first round of , even after all four drugmakers to halt the last month. Merck's Type 2 diabetes drug Januvia, AstraZeneca's own diabetes drug Farxiga,...
2023-09-29 21:47:32